loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (JDMF) for Ozagrel Sodium Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Ozagrel Sodium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    26/09/2024 Daito Pharmaceutical
    Japan
    		 Daito Co., Ltd. 221MF10055 JP Sodium Ozagrel (for manufacturing purposes only) 2009-03-16 2018-08-08 326 Yokamachi, Toyama City, Toyama Prefecture
    26/09/2024 Daito Pharmaceutical
    Japan
    		 Daito Co., Ltd. 217MF10657 Extra-official regulations Sodium ozagrel (for manufact... 2005-09-29 2006-12-18 326 Yokamachi, Toyama City, Toyama Prefecture